Eversept Partners »

Alto Neuroscience shares owned by Eversept Partners

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 125k 22.48

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
GSK Sponsored Adr (GSK)
Vera Therapeutics Cl A (VERA)
Natera (NTRA)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Qiagen Nv Ord Shares (QGEN)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Hca Holdings (HCA)

View all positions for Eversept Partners

Top funds holding Alto Neuroscience

Falcon Edge Capital
Commodore Capital
Vestal Point Capital
Perceptive Advisors
Vanguard Capital Management
Franklin Resources
Vivo Capital
Armistice Capital
Millennium Management
72 Investment Holdings
BlackRock
Susquehanna International
Ikarian Capital
Point72 Asset Management
VR Adviser

View all funds holding Alto Neuroscience